お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、GLP-1薬の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にGLP-1薬市場を分類しています。
本レポートでは世界のGLP-1薬市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Novo Nordisk、Eli Lilly、AstraZeneca、Sanofi、Pfizer Inc、Hanmi Pharmaceutical Co、Teva Pharmaceutical Industries Ltd、Boehringer Ingelheim、GlaxoSmithKline (GSK)、Huadong Medicine、Gan & Lee Pharmaceuticals、Tonghua Dongbao、Shanghai Benemae Pharmaceutical Corporation、Jiangsu Hansoh Pharmaceutical Group Co., Ltd.、PegBio Co., Ltd

レポートはGLP-1薬の主要生産者を調査し、主要地域や国の消費状況も提供します。GLP-1薬の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Short-acting GLP-1 Drug
    Long-acting GLP-1 Drug

用途別の市場セグメント：
    Obesity
    Type 2 Diabetes (T2DM)
    Cardiovascular and Cerebrovascular Diseases (CVD)
    Non-alcoholic Steatohepatitis (NASH)
    Alzheimer's Disease (AD)

本レポートの詳細内容
本レポートは、世界のGLP-1薬市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてGLP-1薬市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）のGLP-1薬生産量、成長率、市場シェアを調査している。

二. 消費面では、GLP-1薬の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのGLP-1薬売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のGLP-1薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本GLP-1薬のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：GLP-1薬のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： GLP-1薬の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおけるGLP-1薬の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章GLP-1薬メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：GLP-1薬の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：GLP-1薬の主要メーカーの概要を提供し、製品の説明と仕様、GLP-1薬の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：GLP-1薬の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global GLP-1 Drug market is projected to grow from US$ 31190 million in 2024 to US$ 123050 million by 2030, at a Compound Annual Growth Rate (CAGR) of 25.7% during the forecast period.
The US & Canada market for GLP-1 Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The China market for GLP-1 Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The Europe market for GLP-1 Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key manufacturers of GLP-1 Drug include Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc, Hanmi Pharmaceutical Co, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim, GlaxoSmithKline (GSK), Huadong Medicine, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for GLP-1 Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of GLP-1 Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for GLP-1 Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the GLP-1 Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global GLP-1 Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for GLP-1 Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc, Hanmi Pharmaceutical Co, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim, GlaxoSmithKline (GSK), Huadong Medicine, etc.

Market Segmentation
By Company
    Novo Nordisk
    Eli Lilly
    AstraZeneca
    Sanofi
    Pfizer Inc
    Hanmi Pharmaceutical Co
    Teva Pharmaceutical Industries Ltd
    Boehringer Ingelheim
    GlaxoSmithKline (GSK)
    Huadong Medicine
    Gan & Lee Pharmaceuticals
    Tonghua Dongbao
    Shanghai Benemae Pharmaceutical Corporation
    Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
    PegBio Co., Ltd

Segment by Type
    Short-acting GLP-1 Drug
    Long-acting GLP-1 Drug

Segment by Application
    Obesity
    Type 2 Diabetes (T2DM)
    Cardiovascular and Cerebrovascular Diseases (CVD)
    Non-alcoholic Steatohepatitis (NASH)
    Alzheimer's Disease (AD)

Segment by region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of GLP-1 Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of GLP-1 Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GLP-1 Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
 Table 1. Global GLP-1 Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Table 2. Major Manufacturers of Short-acting GLP-1 Drug
 Table 3. Major Manufacturers of Long-acting GLP-1 Drug
 Table 4. Global GLP-1 Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Table 5. Global GLP-1 Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 6. Global GLP-1 Drug Revenue by Region (2019-2024) & (US$ Million)
 Table 7. Global GLP-1 Drug Revenue by Region (2025-2030) & (US$ Million)
 Table 8. Global GLP-1 Drug Revenue Market Share by Region (2019-2024)
 Table 9. Global GLP-1 Drug Revenue Market Share by Region (2025-2030)
 Table 10. Global GLP-1 Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Table 11. Global GLP-1 Drug Sales by Region (2019-2024) & (K Units)
 Table 12. Global GLP-1 Drug Sales by Region (2025-2030) & (K Units)
 Table 13. Global GLP-1 Drug Sales Market Share by Region (2019-2024)
 Table 14. Global GLP-1 Drug Sales Market Share by Region (2025-2030)
 Table 15. Global GLP-1 Drug Sales by Manufacturers (2019-2024) & (K Units)
 Table 16. Global GLP-1 Drug Sales Share by Manufacturers (2019-2024)
 Table 17. Global GLP-1 Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
 Table 18. Global GLP-1 Drug Revenue Market Share by Manufacturers (2019-2024)
 Table 19. Global Key Players of GLP-1 Drug, Industry Ranking, 2021 VS 2022 VS 2023
 Table 20. GLP-1 Drug Price by Manufacturers (2019-2024) & (US$/Unit)
 Table 21. Global GLP-1 Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 22. Global GLP-1 Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Drug as of 2023)
 Table 23. Global Key Manufacturers of GLP-1 Drug, Manufacturing Base Distribution and Headquarters
 Table 24. Global Key Manufacturers of GLP-1 Drug, Product Offered and Application
 Table 25. Global Key Manufacturers of GLP-1 Drug, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global GLP-1 Drug Sales by Type (2019-2024) & (K Units)
 Table 28. Global GLP-1 Drug Sales by Type (2025-2030) & (K Units)
 Table 29. Global GLP-1 Drug Sales Share by Type (2019-2024)
 Table 30. Global GLP-1 Drug Sales Share by Type (2025-2030)
 Table 31. Global GLP-1 Drug Revenue by Type (2019-2024) & (US$ Million)
 Table 32. Global GLP-1 Drug Revenue by Type (2025-2030) & (US$ Million)
 Table 33. Global GLP-1 Drug Revenue Share by Type (2019-2024)
 Table 34. Global GLP-1 Drug Revenue Share by Type (2025-2030)
 Table 35. GLP-1 Drug Price by Type (2019-2024) & (US$/Unit)
 Table 36. Global GLP-1 Drug Price Forecast by Type (2025-2030) & (US$/Unit)
 Table 37. Global GLP-1 Drug Sales by Application (2019-2024) & (K Units)
 Table 38. Global GLP-1 Drug Sales by Application (2025-2030) & (K Units)
 Table 39. Global GLP-1 Drug Sales Share by Application (2019-2024)
 Table 40. Global GLP-1 Drug Sales Share by Application (2025-2030)
 Table 41. Global GLP-1 Drug Revenue by Application (2019-2024) & (US$ Million)
 Table 42. Global GLP-1 Drug Revenue by Application (2025-2030) & (US$ Million)
 Table 43. Global GLP-1 Drug Revenue Share by Application (2019-2024)
 Table 44. Global GLP-1 Drug Revenue Share by Application (2025-2030)
 Table 45. GLP-1 Drug Price by Application (2019-2024) & (US$/Unit)
 Table 46. Global GLP-1 Drug Price Forecast by Application (2025-2030) & (US$/Unit)
 Table 47. US & Canada GLP-1 Drug Sales by Type (2019-2024) & (K Units)
 Table 48. US & Canada GLP-1 Drug Sales by Type (2025-2030) & (K Units)
 Table 49. US & Canada GLP-1 Drug Revenue by Type (2019-2024) & (US$ Million)
 Table 50. US & Canada GLP-1 Drug Revenue by Type (2025-2030) & (US$ Million)
 Table 51. US & Canada GLP-1 Drug Sales by Application (2019-2024) & (K Units)
 Table 52. US & Canada GLP-1 Drug Sales by Application (2025-2030) & (K Units)
 Table 53. US & Canada GLP-1 Drug Revenue by Application (2019-2024) & (US$ Million)
 Table 54. US & Canada GLP-1 Drug Revenue by Application (2025-2030) & (US$ Million)
 Table 55. US & Canada GLP-1 Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 56. US & Canada GLP-1 Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 57. US & Canada GLP-1 Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 58. US & Canada GLP-1 Drug Sales by Country (2019-2024) & (K Units)
 Table 59. US & Canada GLP-1 Drug Sales by Country (2025-2030) & (K Units)
 Table 60. Europe GLP-1 Drug Sales by Type (2019-2024) & (K Units)
 Table 61. Europe GLP-1 Drug Sales by Type (2025-2030) & (K Units)
 Table 62. Europe GLP-1 Drug Revenue by Type (2019-2024) & (US$ Million)
 Table 63. Europe GLP-1 Drug Revenue by Type (2025-2030) & (US$ Million)
 Table 64. Europe GLP-1 Drug Sales by Application (2019-2024) & (K Units)
 Table 65. Europe GLP-1 Drug Sales by Application (2025-2030) & (K Units)
 Table 66. Europe GLP-1 Drug Revenue by Application (2019-2024) & (US$ Million)
 Table 67. Europe GLP-1 Drug Revenue by Application (2025-2030) & (US$ Million)
 Table 68. Europe GLP-1 Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 69. Europe GLP-1 Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 70. Europe GLP-1 Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 71. Europe GLP-1 Drug Sales by Country (2019-2024) & (K Units)
 Table 72. Europe GLP-1 Drug Sales by Country (2025-2030) & (K Units)
 Table 73. China GLP-1 Drug Sales by Type (2019-2024) & (K Units)
 Table 74. China GLP-1 Drug Sales by Type (2025-2030) & (K Units)
 Table 75. China GLP-1 Drug Revenue by Type (2019-2024) & (US$ Million)
 Table 76. China GLP-1 Drug Revenue by Type (2025-2030) & (US$ Million)
 Table 77. China GLP-1 Drug Sales by Application (2019-2024) & (K Units)
 Table 78. China GLP-1 Drug Sales by Application (2025-2030) & (K Units)
 Table 79. China GLP-1 Drug Revenue by Application (2019-2024) & (US$ Million)
 Table 80. China GLP-1 Drug Revenue by Application (2025-2030) & (US$ Million)
 Table 81. Asia GLP-1 Drug Sales by Type (2019-2024) & (K Units)
 Table 82. Asia GLP-1 Drug Sales by Type (2025-2030) & (K Units)
 Table 83. Asia GLP-1 Drug Revenue by Type (2019-2024) & (US$ Million)
 Table 84. Asia GLP-1 Drug Revenue by Type (2025-2030) & (US$ Million)
 Table 85. Asia GLP-1 Drug Sales by Application (2019-2024) & (K Units)
 Table 86. Asia GLP-1 Drug Sales by Application (2025-2030) & (K Units)
 Table 87. Asia GLP-1 Drug Revenue by Application (2019-2024) & (US$ Million)
 Table 88. Asia GLP-1 Drug Revenue by Application (2025-2030) & (US$ Million)
 Table 89. Asia GLP-1 Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 90. Asia GLP-1 Drug Revenue by Region (2019-2024) & (US$ Million)
 Table 91. Asia GLP-1 Drug Revenue by Region (2025-2030) & (US$ Million)
 Table 92. Asia GLP-1 Drug Sales by Region (2019-2024) & (K Units)
 Table 93. Asia GLP-1 Drug Sales by Region (2025-2030) & (K Units)
 Table 94. Middle East, Africa and Latin America GLP-1 Drug Sales by Type (2019-2024) & (K Units)
 Table 95. Middle East, Africa and Latin America GLP-1 Drug Sales by Type (2025-2030) & (K Units)
 Table 96. Middle East, Africa and Latin America GLP-1 Drug Revenue by Type (2019-2024) & (US$ Million)
 Table 97. Middle East, Africa and Latin America GLP-1 Drug Revenue by Type (2025-2030) & (US$ Million)
 Table 98. Middle East, Africa and Latin America GLP-1 Drug Sales by Application (2019-2024) & (K Units)
 Table 99. Middle East, Africa and Latin America GLP-1 Drug Sales by Application (2025-2030) & (K Units)
 Table 100. Middle East, Africa and Latin America GLP-1 Drug Revenue by Application (2019-2024) & (US$ Million)
 Table 101. Middle East, Africa and Latin America GLP-1 Drug Revenue by Application (2025-2030) & (US$ Million)
 Table 102. Middle East, Africa and Latin America GLP-1 Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 103. Middle East, Africa and Latin America GLP-1 Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 104. Middle East, Africa and Latin America GLP-1 Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 105. Middle East, Africa and Latin America GLP-1 Drug Sales by Country (2019-2024) & (K Units)
 Table 106. Middle East, Africa and Latin America GLP-1 Drug Sales by Country (2025-2030) & (K Units)
 Table 107. Novo Nordisk Company Information
 Table 108. Novo Nordisk Description and Major Businesses
 Table 109. Novo Nordisk GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 110. Novo Nordisk GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 111. Novo Nordisk Recent Developments
 Table 112. Eli Lilly Company Information
 Table 113. Eli Lilly Description and Major Businesses
 Table 114. Eli Lilly GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 115. Eli Lilly GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 116. Eli Lilly Recent Developments
 Table 117. AstraZeneca Company Information
 Table 118. AstraZeneca Description and Major Businesses
 Table 119. AstraZeneca GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 120. AstraZeneca GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 121. AstraZeneca Recent Developments
 Table 122. Sanofi Company Information
 Table 123. Sanofi Description and Major Businesses
 Table 124. Sanofi GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 125. Sanofi GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 126. Sanofi Recent Developments
 Table 127. Pfizer Inc Company Information
 Table 128. Pfizer Inc Description and Major Businesses
 Table 129. Pfizer Inc GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 130. Pfizer Inc GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 131. Pfizer Inc Recent Developments
 Table 132. Hanmi Pharmaceutical Co Company Information
 Table 133. Hanmi Pharmaceutical Co Description and Major Businesses
 Table 134. Hanmi Pharmaceutical Co GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 135. Hanmi Pharmaceutical Co GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 136. Hanmi Pharmaceutical Co Recent Developments
 Table 137. Teva Pharmaceutical Industries Ltd Company Information
 Table 138. Teva Pharmaceutical Industries Ltd Description and Major Businesses
 Table 139. Teva Pharmaceutical Industries Ltd GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 140. Teva Pharmaceutical Industries Ltd GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 141. Teva Pharmaceutical Industries Ltd Recent Developments
 Table 142. Boehringer Ingelheim Company Information
 Table 143. Boehringer Ingelheim Description and Major Businesses
 Table 144. Boehringer Ingelheim GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 145. Boehringer Ingelheim GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 146. Boehringer Ingelheim Recent Developments
 Table 147. GlaxoSmithKline (GSK) Company Information
 Table 148. GlaxoSmithKline (GSK) Description and Major Businesses
 Table 149. GlaxoSmithKline (GSK) GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 150. GlaxoSmithKline (GSK) GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 151. GlaxoSmithKline (GSK) Recent Developments
 Table 152. Huadong Medicine Company Information
 Table 153. Huadong Medicine Description and Major Businesses
 Table 154. Huadong Medicine GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 155. Huadong Medicine GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 156. Huadong Medicine Recent Developments
 Table 157. Gan & Lee Pharmaceuticals Company Information
 Table 158. Gan & Lee Pharmaceuticals Description and Major Businesses
 Table 159. Gan & Lee Pharmaceuticals GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 160. Gan & Lee Pharmaceuticals GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 161. Gan & Lee Pharmaceuticals Recent Developments
 Table 162. Tonghua Dongbao Company Information
 Table 163. Tonghua Dongbao Description and Major Businesses
 Table 164. Tonghua Dongbao GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 165. Tonghua Dongbao GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 166. Tonghua Dongbao Recent Developments
 Table 167. Shanghai Benemae Pharmaceutical Corporation Company Information
 Table 168. Shanghai Benemae Pharmaceutical Corporation Description and Major Businesses
 Table 169. Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 170. Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 171. Shanghai Benemae Pharmaceutical Corporation Recent Developments
 Table 172. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
 Table 173. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Description and Major Businesses
 Table 174. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 175. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 176. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments
 Table 177. PegBio Co., Ltd Company Information
 Table 178. PegBio Co., Ltd Description and Major Businesses
 Table 179. PegBio Co., Ltd GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 180. PegBio Co., Ltd GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
 Table 181. PegBio Co., Ltd Recent Developments
 Table 182. Key Raw Materials Lists
 Table 183. Raw Materials Key Suppliers Lists
 Table 184. GLP-1 Drug Distributors List
 Table 185. GLP-1 Drug Customers List
 Table 186. GLP-1 Drug Market Trends
 Table 187. GLP-1 Drug Market Drivers
 Table 188. GLP-1 Drug Market Challenges
 Table 189. GLP-1 Drug Market Restraints
 Table 190. Research Programs/Design for This Report
 Table 191. Key Data Information from Secondary Sources
 Table 192. Key Data Information from Primary Sources


List of Figures
 Figure 1. GLP-1 Drug Product Picture
 Figure 2. Global GLP-1 Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global GLP-1 Drug Market Share by Type: 2023 & 2030
 Figure 4. Short-acting GLP-1 Drug Product Picture
 Figure 5. Long-acting GLP-1 Drug Product Picture
 Figure 6. Global GLP-1 Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 7. Global GLP-1 Drug Market Share by Application: 2023 & 2030
 Figure 8. Obesity
 Figure 9. Type 2 Diabetes (T2DM)
 Figure 10. Cardiovascular and Cerebrovascular Diseases (CVD)
 Figure 11. Non-alcoholic Steatohepatitis (NASH)
 Figure 12. Alzheimer's Disease (AD)
 Figure 13. GLP-1 Drug Report Years Considered
 Figure 14. Global GLP-1 Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 16. Global GLP-1 Drug Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 17. Global GLP-1 Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
 Figure 18. Global GLP-1 Drug Revenue Market Share by Region (2019-2030)
 Figure 19. Global GLP-1 Drug Sales (2019-2030) & (K Units)
 Figure 20. Global GLP-1 Drug Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Figure 21. Global GLP-1 Drug Sales Market Share by Region (2019-2030)
 Figure 22. US & Canada GLP-1 Drug Sales YoY (2019-2030) & (K Units)
 Figure 23. US & Canada GLP-1 Drug Revenue YoY (2019-2030) & (US$ Million)
 Figure 24. Europe GLP-1 Drug Sales YoY (2019-2030) & (K Units)
 Figure 25. Europe GLP-1 Drug Revenue YoY (2019-2030) & (US$ Million)
 Figure 26. China GLP-1 Drug Sales YoY (2019-2030) & (K Units)
 Figure 27. China GLP-1 Drug Revenue YoY (2019-2030) & (US$ Million)
 Figure 28. Asia (excluding China) GLP-1 Drug Sales YoY (2019-2030) & (K Units)
 Figure 29. Asia (excluding China) GLP-1 Drug Revenue YoY (2019-2030) & (US$ Million)
 Figure 30. Middle East, Africa and Latin America GLP-1 Drug Sales YoY (2019-2030) & (K Units)
 Figure 31. Middle East, Africa and Latin America GLP-1 Drug Revenue YoY (2019-2030) & (US$ Million)
 Figure 32. Global GLP-1 Drug Sales Share by Manufacturers (2023)
 Figure 33. The GLP-1 Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
 Figure 34. Global GLP-1 Drug Revenue Share by Manufacturers (2023)
 Figure 35. The Top 5 and 10 Largest Manufacturers of GLP-1 Drug in the World: Market Share by GLP-1 Drug Revenue in 2023
 Figure 36. Global GLP-1 Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 37. Global GLP-1 Drug Sales Market Share by Type (2019-2030)
 Figure 38. Global GLP-1 Drug Revenue Market Share by Type (2019-2030)
 Figure 39. Global GLP-1 Drug Sales Market Share by Application (2019-2030)
 Figure 40. Global GLP-1 Drug Revenue Market Share by Application (2019-2030)
 Figure 41. US & Canada GLP-1 Drug Sales Market Share by Type (2019-2030)
 Figure 42. US & Canada GLP-1 Drug Revenue Market Share by Type (2019-2030)
 Figure 43. US & Canada GLP-1 Drug Sales Market Share by Application (2019-2030)
 Figure 44. US & Canada GLP-1 Drug Revenue Market Share by Application (2019-2030)
 Figure 45. US & Canada GLP-1 Drug Revenue Share by Country (2019-2030)
 Figure 46. US & Canada GLP-1 Drug Sales Share by Country (2019-2030)
 Figure 47. US GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 48. Canada GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 49. Europe GLP-1 Drug Sales Market Share by Type (2019-2030)
 Figure 50. Europe GLP-1 Drug Revenue Market Share by Type (2019-2030)
 Figure 51. Europe GLP-1 Drug Sales Market Share by Application (2019-2030)
 Figure 52. Europe GLP-1 Drug Revenue Market Share by Application (2019-2030)
 Figure 53. Europe GLP-1 Drug Revenue Share by Country (2019-2030)
 Figure 54. Europe GLP-1 Drug Sales Share by Country (2019-2030)
 Figure 55. Germany GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 56. France GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 57. U.K. GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 58. Italy GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 59. Russia GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 60. China GLP-1 Drug Sales Market Share by Type (2019-2030)
 Figure 61. China GLP-1 Drug Revenue Market Share by Type (2019-2030)
 Figure 62. China GLP-1 Drug Sales Market Share by Application (2019-2030)
 Figure 63. China GLP-1 Drug Revenue Market Share by Application (2019-2030)
 Figure 64. Asia GLP-1 Drug Sales Market Share by Type (2019-2030)
 Figure 65. Asia GLP-1 Drug Revenue Market Share by Type (2019-2030)
 Figure 66. Asia GLP-1 Drug Sales Market Share by Application (2019-2030)
 Figure 67. Asia GLP-1 Drug Revenue Market Share by Application (2019-2030)
 Figure 68. Asia GLP-1 Drug Revenue Share by Region (2019-2030)
 Figure 69. Asia GLP-1 Drug Sales Share by Region (2019-2030)
 Figure 70. Japan GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 71. South Korea GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 72. China Taiwan GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 73. Southeast Asia GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 74. India GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 75. Australia GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 76. Middle East, Africa and Latin America GLP-1 Drug Sales Market Share by Type (2019-2030)
 Figure 77. Middle East, Africa and Latin America GLP-1 Drug Revenue Market Share by Type (2019-2030)
 Figure 78. Middle East, Africa and Latin America GLP-1 Drug Sales Market Share by Application (2019-2030)
 Figure 79. Middle East, Africa and Latin America GLP-1 Drug Revenue Market Share by Application (2019-2030)
 Figure 80. Middle East, Africa and Latin America GLP-1 Drug Revenue Share by Country (2019-2030)
 Figure 81. Middle East, Africa and Latin America GLP-1 Drug Sales Share by Country (2019-2030)
 Figure 82. Brazil GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 83. Mexico GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 84. Turkey GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 85. Israel GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 86. GCC Countries GLP-1 Drug Revenue (2019-2030) & (US$ Million)
 Figure 87. GLP-1 Drug Value Chain
 Figure 88. GLP-1 Drug Production Process
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed